Seeing Is Believing
BLTE is currently covered by 5 analysts with an average price target of $211.7. This is a potential upside of $48.49 (21.81%) from yesterday's end of day stock price of $173.79.
Belite Bio ADR's activity chart (see below) currently has 33 price targets and 51 ratings on display. The stock rating distribution of BLTE is 90.48% BUY and 9.52% HOLD.
Analysts average stock forecasts to be materialized ratio is 59.54% with an average time for these price targets to be met of 165 days.
Highest price target for BLTE is $270, Lowest price target is $140, average price target is $211.7.
Most recent stock forecast was given by GRAIG SUVANNAVEJH from MIZUHO. First documented stock forecast 01-Jul-2022.
Currently out of the existing stock ratings of BLTE, 19 are a BUY (90.48%), 2 are a HOLD (9.52%).
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 26-May-2026
$234
$60.21 (34.65%)
$215
Buy Since 01-Aug-2022
$245
$71.21 (40.97%)
$214
Buy Since 05-Jan-2026
$206
$32.21 (18.53%)
$201
1 months ago
(14-Aug-2026)
1/3 (33.33%)
$43.2 (26.54%)
241
Buy Since 02-Mar-2026
$270
$96.21 (55.36%)
$266
1 months ago
(14-Aug-2026)
1/3 (33.33%)
$107.2 (65.85%)
7
Buy Since 14-Dec-2023
$140
$-8.73 (-5.87%)
$110
10 months 3 days ago
(11-Nov-2025)
3/3 (100%)
$34.24 (32.38%)
229
What is BLTE (Belite Bio ADR) average time for price targets to be met?
Which analyst most recently updated their price target on BLTE (Belite Bio ADR)?
Which analyst has the most public recommendations on BLTE (Belite Bio ADR)?
Which analyst is the currently most bullish on BLTE (Belite Bio ADR)?
Which analyst is the currently most reserved on BLTE (Belite Bio ADR)?